مقارنة الدوكسي سيكلين الفموي مع الأزيترومايسين الفموي في علاج العدّ الشائع

Authors

  • رولا بدور

Abstract

this study has included 78 Patients having acne vulgaris on face. Patients were randomily divided into two groups, Patients in first group were given azithromycin 500 mg daily before meal for 3 consecutive days monthly for 3 months while Patients in second group were given doxycycline 100 mg daily after meals for 3 months. Patients were followed up after taking treatment for 1 month and 3 months to see the response and tolerance of each drug.

Result: there was no significant difference between two groups regarding the amount of decrease in acne severity index across the study but azithromycin was more tolerable than doxycycline.

 

تمّت الدراسة على 78 مريضاً لديهم عُدّ شائع في الوجه. تم تقسيم المرضى إلى مجموعتين، تلقّت المجموعة الاولى الأزيترومايسين النبضي بجرعة 500 ملغ يومياً على الريق لـ 3 أيام متتالية بفواصل شهرية ولمدة ثلاثة أشهر، فيما تلقّت المجموعة الثانية دوكسي سيكلين بجرعة 100 ملغ يومياً بعد الطعام لمدة 3 أشهر. تم متابعة المرضى بعد تلقي العلاج وذلك بعد شهر وبعد ثلاثة أشهر لتسجيل الاستجابة وكذلك التحمّل لكلا العقارين.

بالنتيجة، كانت الاستجابة لكلا الدوائين متقاربة فيما يتعلق بتحسُّن مشعر شدة العدّ مع وجود فارق هام إحصائياً(P=0.186)في حين كان تحمّل الأزيترومايسين افضل من تحمل الدوكسي سيكلين.

 

Downloads

Published

2019-10-31

How to Cite

1.
بدور ر. مقارنة الدوكسي سيكلين الفموي مع الأزيترومايسين الفموي في علاج العدّ الشائع. Tuj-hlth [Internet]. 2019Oct.31 [cited 2024Apr.20];41(5). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/9128

Issue

Vol. 41 No. 5 (2019): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)